The atypical neurotherapeutic chosen for strategic optimization, CANTOR (CM 30038; minaprine), showed low risk for cardiotoxicity, drowsiness, or weight gain in neurology patients plus a suggestive trend in AD patient cognitive improvement.
← all excerpts
Optimized 5-HT<sub>2b</sub> inhibitors for neuropsychiatric syndromes with cognitive dysfunction.
1
—
—